|
Sex, M/F
|
18/39
|
|
Age (range), years
|
47.3 ± 13.3 (20–81)
|
|
Smoker/nonsmoker
|
4/53
|
|
Wheezing onset age (range), years
|
10.2 ± 4.5 (1–16)
|
|
Duration of wheezing (range), years
|
38.1 ± 12.7 (10–70)
|
|
Lung function test
| |
|
FVC, L (% predicted)
|
3.1 ± 0.9 (93.2 ± 20.6%)
|
|
FEV1, L (% predicted)
|
1.67 ± 0.7 (62.8 ± 21.8%)
|
|
FEF, L/sec (% predicted)
|
4.5 ± 2.2 (66.9 ± 26.3%)
|
|
FEV1/FVC
|
54.6 ± 14.9%
|
|
FEV1/FVC < 70%, 30%–49%, < 30%
|
17 (29.8%), 13 (22.8%), 1 (1.8%)
|
|
Blood eosinophil count, cells/mm
3
(P%)
|
305.2 ± 325.3 (17.5%)
|
|
Esophageal endoscopy
| |
|
Esophagitis (P%)
|
27 (47.4%)
|
|
LA-A, LA-B, LA-C, LA-D
|
14, 10, 2, 1
|
|
Barrett esophagus (P%)
|
1 (1.8%)
|
|
Hiatal hernia (P%)
|
20 (35.1%)
|
|
Dual 24 hour pH monitoring
| |
|
Distal channel DMS (P%)
|
41.94 ± 59.11 (64.9%)
|
|
Proximal channel DMS (rang)
|
8.12 ± 10.23 (0.20 - 50.77)
|
|
High-resolution manometry
| |
|
MUESP, mmHg (P%)
|
41.2 ± 22.7 (50.9%)
|
|
MLESP, mmHg (P%)
|
14.2 ± 6.9 (43.9%)
|
|
LHPZ, cm (P%)
|
2.9 ± 0.7 (35.1%)
|
|
Esophageal dyskinesia
|
26 (45.6%)
|
